帕博利珠单抗联合化疗应用于早期三阴性乳腺癌新辅助治疗中的首个前瞻性随机对照Ⅲ期临床研究
The First Prospective Randomized Controlled Phase ⅢClinical Study of Pembrolizumab Combined With Chemotherapy as Neoadjuvant Treatment for Early Triple-Negative Breast Cancer
帕博利珠单抗联合化疗应用于早期三阴性乳腺癌新辅助治疗中的首个前瞻性随机对照Ⅲ期临床研究 |
| 评价者：杨辞秋, 王坤, 文献合成者：陈媛琪 |
The First Prospective Randomized Controlled Phase ⅢClinical Study of Pembrolizumab Combined With Chemotherapy as Neoadjuvant Treatment for Early Triple-Negative Breast Cancer |
| |